Page last updated: 2024-08-17

carbostyril and Amphetamine-Related Disorders

carbostyril has been researched along with Amphetamine-Related Disorders in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Correll, CU; Iwata, N; Kishi, T; Matsuda, Y	1
Abad, A; Anderson, A; Condos, R; De La Garza, R; Elkashef, A; Halkitis, PN; Li, SH; Mahoney, JJ; Mojisak, J; Newton, TF; Palamar, J; Reid, MS	1
Gill, JS; Guan, NC; Hussein, HM; Said, MA; Sulaiman, AH; Zainal, NZ	1
Coffin, PO; Colfax, GN; Das, M; Gasper, J; Huffaker, S; Matheson, T; Santos, DM; Santos, GM; Vittinghoff, E	1
Stoops, WW	1
Föhr, J; Haukka, J; Kuikanmäki, O; Kuoppasalmi, K; Meririnne, E; Sokero, P; Tiihonen, J; Tuomola, P; Vorma, H	1
Koob, GF; Pulvirenti, L; Wang, Z; Wee, S; Woolverton, WL	1
Gardner, TJ; Kosten, TR	1

Reviews

1 review(s) available for carbostyril and Amphetamine-Related Disorders

Article	Year
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:12 Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome	2013

Article

Year

Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.

The Journal of clinical psychiatry, 2013, Volume: 74, Issue:12

Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome

2013

Trials

4 trial(s) available for carbostyril and Amphetamine-Related Disorders

Article	Year
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:8 Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Area Under Curve; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Methamphetamine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Socioeconomic Factors	2008
A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis. International journal of psychiatry in clinical practice, 2013, Volume: 17, Issue:2 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Patient Compliance; Piperazines; Psychoses, Substance-Induced; Quinolones	2013
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction (Abingdon, England), 2013, Volume: 108, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Aripiprazole; Combined Modality Therapy; Counseling; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Medication Adherence; Methamphetamine; Piperazines; Quinolones; Substance Abuse Detection; Treatment Failure	2013
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. The American journal of psychiatry, 2007, Volume: 164, Issue:1 Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Aripiprazole; Female; Humans; Male; Methylphenidate; Piperazines; Placebos; Quinolones; Severity of Illness Index; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome	2007

Other Studies

3 other study(ies) available for carbostyril and Amphetamine-Related Disorders

Article	Year
Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine. Experimental and clinical psychopharmacology, 2006, Volume: 14, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Area Under Curve; Aripiprazole; Central Nervous System Stimulants; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Humans; Piperazines; Psychomotor Performance; Quinolones	2006
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:10 Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Aripiprazole; Brain; Brain Chemistry; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Nucleus Accumbens; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Self Administration	2007
Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:6 Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Brain; Cocaine-Related Disorders; Diffusion Magnetic Resonance Imaging; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quinolones; Substance-Related Disorders	2007